Dec 20, 2018 · Cumulative incidence of nonrelapse mortality (NRM) for patients <45-year old at transplant was 7% rising to 25% for patients aged ≥65. For older ...
Dec 20, 2018 · Overall survival probability was 53% at 2 years and 35% at 10 years post-alloHCT. Survival probability at 5 years from the 2-year landmark was ...
Overall survival probability was 53% at 2 years and 35% at 10 years post-alloHCT. Survival probability at 5 years from the 2-year landmark was 88% for patients ...
Schetelig, Johannes ; de Wreede, Liesbeth C. ; van Gelder, Michel et al. / Late treatment-related mortality versus competing causes of death after allogeneic ...
Overall survival probability was 53% at 2 years and 35% at 10 years post-alloHCT. Survival probability at 5 years from the 2-year landmark was 88% for patients ...
View statistics · In Collections · Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic ...
Sep 1, 2019 · Patients with MF have good survival when alive and in remission two years after transplantation, especially younger and female recipients.
Apr 4, 2024 · In the remission induction group, day 28 mortality after allogeneic HSCT was lower among patients who proceeded to allogeneic HSCT in complete ...
Missing: Late | Show results with:Late
People also ask
What is the survival rate for AML patients after stem cell transplant?
What are the odds of AML coming back after bone marrow transplant?
What is the survival rate for leukemia relapse after bone marrow transplant?
What is the mortality rate for allogeneic stem cell transplant?
Apr 4, 2011 · Most deaths after HCT occur within the first 2 years as a result of relapse, acute or chronic graft-versus-host disease (GVHD), infection, or ...
Missing: syndromes | Show results with:syndromes
May 28, 2016 · Long-term survivors after allogeneic HCT are at higher risk of mortality from various causes other than the underlying disease that led to HCT.